生物技术公司Araceli Biosciences完成1120万美元种子轮融资，推动药物研发变革步伐-动脉网

Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery

CISION 等信源发布 2025-04-24 21:00



可切换为仅中文







PORTLAND, Ore.

俄勒冈州波特兰

，

April 24, 2025

2025年4月24日

/PRNewswire/ -- Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising

/PRNewswire/ -- Araceli Biosciences，一家引领高内涵成像和人工智能分析革命的先锋生物技术公司，今天宣布成功完成了其种子轮融资，筹集了

$7.2 million

720万美元

in new equity investment and converting

新股权融资并转换

$4.0 million

400万美元

in SAFEs, bringing total financing since Araceli's spinout from Phoseon Technology to

在SAFE中，自Araceli从Phoseon Technology分拆出来以来，总融资额达到了

$11.2M

1120万美元

. This funding will accelerate Araceli's commercial expansion, scale manufacturing, and advance its next-generation AI-driven product offerings in high-content imaging.

这笔资金将加速Araceli的商业扩展、规模化生产，并推动其在高内涵成像领域的下一代人工智能驱动产品的发展。

继续阅读

Disrupting the Imaging Bottleneck in Drug Discovery

打破药物发现中的成像瓶颈

The Endeavor® High Content Imaging System is Araceli's flagship platform, designed for ultra high-throughput imaging with exceptional data—delivering results up to 40x faster than traditional systems across a broad range of cellular assays. Paired with Clairvoyance, Araceli's AI-driven analysis software, the platform delivers rapid, actionable insights that streamline workflows, reduce experimental errors, and dramatically speed up drug discovery timelines..

Endeavor®高内涵成像系统是Araceli的旗舰平台，专为超高通量成像而设计，数据卓越——在广泛的细胞检测中，其结果比传统系统快多达40倍。该平台与Araceli的AI驱动分析软件Clairvoyance相结合，提供快速且可操作的洞察，优化工作流程，减少实验误差，并大幅加快药物发现的时间进程。

The old model of waiting hours for data is over. At Araceli, we're building a platform that moves at the speed of science.

旧的等待数据数小时的模式已经结束。在Araceli，我们正在构建一个以科学速度前进的平台。

Post this

发布这个

While advances in automation, genomics, and machine learning have transformed drug discovery, high-content imaging remains one of the slowest steps and a major bottleneck. Traditional imaging systems lack the speed and scalability required for modern AI-driven pipelines and multiplexed assays. Araceli addresses this critical gap with a platform purpose-built for speed, scale, and seamless AI integration—enabling researchers to generate more data, faster, with greater precision..

虽然自动化、基因组学和机器学习的进步已经改变了药物发现的进程，但高内涵成像仍然是最慢的步骤之一，也是主要的瓶颈。传统的成像系统缺乏现代人工智能驱动流程和多重分析所需的速度和可扩展性。Araceli 通过一个专为速度、规模和无缝人工智能集成而构建的平台来解决这一关键差距，使研究人员能够更快、更精确地生成更多数据。

Strategic Use of Funds

战略资金运用

Proceeds from the Seed round will support:

种子轮融资将用于支持：

Scaling operational infrastructure to meet growing demand

扩展运营基础设施以满足不断增长的需求

Advancing market applications, including personalized medicine

推进市场应用，包括个性化医疗

Advancing the platform's hardware and software for real-time analysis capabilities

推进平台的硬件和软件以实现实时分析能力

Expanding marketing and business development efforts

扩大营销和业务发展工作

'The future of AI-driven drug discovery and personalized medicine depends on imaging and analysis that happens in real time,' said

“人工智能驱动的药物发现和个性化医疗的未来取决于实时发生的成像和分析，”

Matt Beaudet

马特·博德特

, CEO of Araceli Biosciences. 'Minutes and seconds matter. The old model of waiting hours—or even days—for data is over. At Araceli, we're building a platform that moves at the speed of science.'

Araceli Biosciences首席执行官表示：“分分秒秒都至关重要。等待数小时甚至数天获取数据的旧模式已经结束。在Araceli，我们正在构建一个以科学速度运行的平台。”

Bill Cortelyou

比尔·科尔特利尤

, Board Chairman and lead investor, added, 'Araceli's breakthrough technology, experienced leadership, and clear market demand position the company well for significant growth potential.'

董事会主席兼首席投资者补充道：“Araceli 的突破性技术、经验丰富的领导团队以及明确的市场需求，使公司具备巨大的增长潜力。”

About Araceli Biosciences

关于阿拉塞利生物科学

Araceli Biosciences is a biotechnology company focused on accelerating drug discovery through innovations in high-content imaging and AI-driven analysis. With its flagship Endeavor® system and Clairvoyance software, Araceli empowers scientists to generate actionable insights faster and more efficiently across a wide range of biological applications..

Araceli Biosciences是一家生物技术公司，专注于通过高内涵成像和人工智能驱动分析的创新来加速药物发现。凭借其旗舰产品Endeavor®系统和Clairvoyance软件，Araceli助力科学家在广泛的生物应用领域中更快、更高效地生成可操作的见解。

Corporate Contact:

公司联系人：

Shawn MacDonald CFO, Araceli Biosciences

肖恩·麦克唐纳，Araceli Biosciences首席财务官

corporaterelations@aracelibio.com

企业关系@阿拉塞利比奥.com

https://www.aracelibio.com/Corporate-Relations

https://www.aracelibio.com/企业关系

SOURCE Araceli Biosciences

来源：Araceli Biosciences

WANT YOUR COMPANY'S NEWS